We are live on ! Find out more
Capital Analysts LLC

Capital Analysts LLC Portfolio holdings

AUM $4.34B Turnover 9.37%
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-5.79%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$523M
AUM Growth
+$34.2M
Cap. Flow
+$68.6M
Cap. Flow %
13.11%
Top 10 Hldgs %
36.69%
Holding
403
New
32
Increased
241
Reduced
45
Closed
49
Avg Time Held
1.5 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
EEMV icon
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
+$14.2M
2
CAH icon
Cardinal Health
CAH
+$5.92M
3
DIS icon
Walt Disney
DIS
+$5.65M
4
BXP icon
Boston Properties
BXP
+$5.35M
5
CVS icon
CVS Health
CVS
+$5.11M

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$19.4M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$10.7M
3
ICF icon
iShares Select U.S. REIT ETF
ICF
+$4.22M
4
EBAY icon
eBay
EBAY
+$3.04M
5
PNR icon
Pentair
PNR
+$2.74M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.91%
2 Financials 6.73%
3 Healthcare 6.31%
4 Consumer Discretionary 5.28%
5 Industrials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
XLV icon
176
State Street Health Care Select Sector SPDR ETF
XLV
$46B
$235K 0.04%
3,550
+975
+38% +$71.3K
2013 Q2
9 quarters
AGU
177
DELISTED
Agrium
AGU
$230K 0.04%
2,566
+1,558
+155% +$158K
2013 Q4
7 quarters
AVT icon
178
Avnet
AVT
$7.56B
$225K 0.04%
5,262
+3,194
+154% +$133K
2013 Q2
9 quarters
BIO icon
179
Bio-Rad Laboratories Class A
BIO
$9.57B
$221K 0.04%
1,642
+997
+155% +$143K
2013 Q3
8 quarters
ORCL icon
180
Oracle
ORCL
$396B
$216K 0.04%
5,982
+1,211
+25% +$46.6K
2013 Q2
9 quarters
GS icon
181
Goldman Sachs
GS
$262B
$215K 0.04%
1,238
-95
-7% -$18.6K
2013 Q2
9 quarters
TQQQ icon
182
ProShares UltraPro QQQ
TQQQ
$34.9B
$209K 0.04%
115,200
– –
2014 Q1
6 quarters
AGN
183
DELISTED
Allergan plc
AGN
$204K 0.04%
750
+475
+173% +$146K
2014 Q2
5 quarters
ECON icon
184
Columbia Emerging Markets Consumer ETF
ECON
$296M
$199K 0.04%
+9,180
New +$217K
2015 Q3
0 quarters
AGCO icon
185
AGCO
AGCO
$7.36B
$197K 0.04%
4,228
+2,074
+96% +$106K
2013 Q2
9 quarters
NEU icon
186
NewMarket
NEU
$8.16B
$192K 0.04%
539
+44
+9% +$17.8K
2013 Q2
9 quarters
HEDJ icon
187
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.75B
$191K 0.04%
7,000
+1,000
+17% +$30.1K
2015 Q1
2 quarters
WSO icon
188
Watsco Inc
WSO
$12.2B
$183K 0.04%
1,545
+60
+4% +$7.48K
2013 Q2
9 quarters
AFL icon
189
Aflac
AFL
$59.6B
$181K 0.03%
6,220
+3,820
+159% +$116K
2013 Q2
9 quarters
WAB icon
190
Wabtec
WAB
$49B
$177K 0.03%
2,015
+80
+4% +$7.63K
2013 Q2
9 quarters
HAL icon
191
Halliburton
HAL
$27.9B
$177K 0.03%
5,002
+837
+20% +$32.9K
2013 Q2
9 quarters
AAL icon
192
American Airlines Group
AAL
$8.17B
$173K 0.03%
4,460
+2,230
+100% +$91.6K
2014 Q2
5 quarters
MIDD icon
193
Middleby
MIDD
$4.95B
$168K 0.03%
1,595
+70
+5% +$8.06K
2014 Q2
5 quarters
ARE icon
194
Alexandria Real Estate Equities
ARE
$7.26B
$167K 0.03%
1,977
+1,044
+112% +$93.9K
2013 Q2
9 quarters
NVS icon
195
Novartis
NVS
$288B
$162K 0.03%
1,962
+842
+75% +$74.9K
2014 Q4
3 quarters
TWX
196
DELISTED
Time Warner Inc
TWX
$156K 0.03%
2,275
-4,408
-66% -$346K
2013 Q2
9 quarters
MSGS icon
197
Madison Square Garden
MSGS
$9.65B
$156K 0.03%
3,028
+105
+4% +$5.77K
2014 Q2
5 quarters
SYY icon
198
Sysco
SYY
$40.5B
$154K 0.03%
3,958
+847
+27% +$32.3K
2013 Q2
9 quarters
ACH icon
199
Accendra Health
ACH
$21.6M
$152K 0.03%
4,751
+1,130
+31% +$38.5K
2013 Q2
9 quarters
AMP icon
200
Ameriprise Financial
AMP
$44.6B
$148K 0.03%
1,360
+680
+100% +$80.2K
2013 Q2
9 quarters
6 7
8
9 10

Similar funds

Channing Capital Management
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return
BDT Capital Partners
BDT Capital Partners Chicago, Illinois $4.35B AUM 21.31% 1-Year Est. Return
Geneva Capital Management
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Regents of the University of California
Regents of the University of California Oakland, California $4.36B AUM 33.89% 1-Year Est. Return
Alesco Advisors
Alesco Advisors Pittsford, New York $4.36B AUM 19.15% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Capital Analysts LLC's Q3 2015 Portfolio in Review

As of Q3 2015, Capital Analysts LLC held 403 positions worth $523M, up 7% from $489M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Capital Analysts LLC deployed $68.6M of net new capital in Q3 2015, opening 32 new positions and adding to 241 existing holdings. Its largest new stake was iShares MSCI Emerging Markets Min Vol Factor ETF: 267,612 shares worth $13.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $19.4M trimmed.

  • Capital Analysts LLC's largest Q3 2015 buy was iShares MSCI Emerging Markets Min Vol Factor ETF: 267,612 shares worth $13.3M.
  • Capital Analysts LLC added most to Cardinal Health in Q3 2015, an estimated $5.92M increase.
  • Capital Analysts LLC's biggest Q3 2015 reduction was iShares Russell 3000 ETF, cutting an estimated $19.4M.
  • Capital Analysts LLC fully exited Pentair in Q3 2015, selling an estimated $2.74M.
  • Capital Analysts LLC's ten largest holdings make up 37% of its $523M portfolio in Q3 2015.
  • Capital Analysts LLC opened 32 new positions and closed 49 in Q3 2015.
  • Capital Analysts LLC's portfolio value rose 7% quarter-over-quarter to $523M.

Based on Capital Analysts LLC's 13F filing for Q3 2015, filed 13 Nov 2015.